BALPHARMA.BOBALPHARMA.BOBSE
Loading
Debt to Equity Over TimeNormalizing
Percentile Rank71
3Y CAGR+2.2%
5Y CAGR-3.3%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+2.2%/yr
vs +1.8%/yr prior
5Y CAGR
-3.3%/yr
Recent acceleration
Acceleration
+0.4pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.94 | -5.4% |
| 2024 | 2.05 | -1.6% |
| 2023 | 2.09 | +14.7% |
| 2022 | 1.82 | -12.9% |
| 2021 | 2.09 | -9.0% |
| 2020 | 2.30 | +23.9% |
| 2019 | 1.85 | +9.5% |
| 2018 | 1.69 | +14.5% |
| 2017 | 1.48 | -4.6% |
| 2016 | 1.55 | - |